Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to Clinical Pharmacology

Academy of Managed Care Pharmacy (AMCP)

Exploring Opportunities to Improve the Quality of Life for Those with Amyotrophic Lateral Sclerosis (ALS)

Clinical Pharmacology June 1st 2023

Addiction Professional

New Opioid Overdose Reversal Nasal Spray Receives FDA Approval

Clinical Pharmacology June 1st 2023

SingleCare

2 Foods to Avoid While on Eliquis

Cardiology May 31st 2023

Journal of Pharmaceutical Policy and Practice

Patients’ Views and Experiences on the Use and Safety of Directly Acting Oral Anticoagulants: A Qualitative Study

Cardiology May 31st 2023

Pharmacy Practice News

Semaglutide Shortage Puts Pharmacy Compounders in Spotlight

Clinical Pharmacology May 31st 2023

Pharmacy Today

Gender-affirming Care and Pharmacy Practice

Explore a course created to equip pharmacists with the knowledge and abilities to assist patients who identify as transgender or gender nonconforming (TGND). The educational program “Gender-Affirming Care in Pharmacy Practice” is a comprehensive guide for pharmacists to better serve transgender and gender-diverse (TGD) patients. It provides a deep understanding of the terminology related to TGD patient populations, including definitions of gender identity, gender expression, and various gender identities. The program emphasizes the importance of gender-affirming care, which includes social, medical, psychological, and behavioral care that aligns with a person’s gender identity. It also provides guidance on how to communicate inclusively with TGD patients, such as introducing oneself with name and pronouns, asking open-ended questions, and avoiding unnecessary or invasive questions. Furthermore, the program highlights the health disparities faced by TGD individuals seeking gender-affirming care, such as higher levels of unemployment and healthcare discrimination. It also discusses the coverage of gender-affirming care by Medicaid, which varies across states. The program provides detailed information on hormone therapy for TGD patients, including testosterone and estrogen hormone therapy. It discusses the potential side effects, contraindications, and the importance of contraception for patients at risk of becoming pregnant while on testosterone therapy. Lastly, the […]

Clinical Pharmacology May 31st 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form